A carregar...
Novel neurosensory testing in cancer patients treated with the epothilone B analog, ixabepilone
Background: We have previously established the recommended phase II dose (RPTD) of ixabepilone as 40 mg/m(2) administered over 1 h repeated every 3 weeks with neuropathy as a cumulative dose-limiting toxicity. We expanded the cohort at the RPTD to include detailed assessment of nerve damage in these...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2733111/ https://ncbi.nlm.nih.gov/pubmed/18644829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdn420 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|